Funder
National Natural Science Foundation of China
Reference5 articles.
1. Current immunotherapies for glioblastoma multiforme;Huang;Front Immunol,2020
2. Refining the 22q11.2 deletion breakpoints in DiGeorge syndrome by aCGH;Bittel;Cytogenet Genome Res,2009
3. HIC2 controls developmental hemoglobin switching by repressing BCL11A transcription;Huang;Nat Genet,2022
4. Hypermethylation of HIC2 is a potential prognostic biomarker and tumor suppressor of glioma based on bioinformatics analysis and experiments;Luo;CNS Neurosci Ther,2023
5. [CDK1 expression and effects of CDK1 silencing on the malignant phenotype of glioma cells];Chen;Zhonghua Zhongliu Zazhi,2007